Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15465979 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Ondansetron;   Drug: Pill placebo;   Drug: Atypical antipsychotic drug

Indicates status has not been verified in more than two years